Mutation screening of splice sites of exon12 of BRCA2 in breast cancer - Mohamed, Hala Taha
40,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
20 °P sammeln
  • Broschiertes Buch

Several breast cancer susceptibility genes had been identified; among those are BRCA1 and BRCA2. Breast cancer is the predominant phenotype associated with mutations in BRCA1 and BRCA2 genes. However, the rate of mutations within the coding regions of the breast cancer susceptibility gene BRCA2 does not fairly explain the pathogenecity of the disease, nor accounting for all disease causing mutations. The aim of this study was to detect mutations that might affect the splicing of exon12 of the BRCA2 gene and thus modulating the functions of BRCA2 12 variant in particular and its contribution to…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Several breast cancer susceptibility genes had been identified; among those are BRCA1 and BRCA2. Breast cancer is the predominant phenotype associated with mutations in BRCA1 and BRCA2 genes. However, the rate of mutations within the coding regions of the breast cancer susceptibility gene BRCA2 does not fairly explain the pathogenecity of the disease, nor accounting for all disease causing mutations. The aim of this study was to detect mutations that might affect the splicing of exon12 of the BRCA2 gene and thus modulating the functions of BRCA2 12 variant in particular and its contribution to the overall biological functions of BRCA2 in DNA repair and tumor suppression. The structural and functional consequences for the corresponding protein will help to understand the role played by different BRCA2 variants in breast cancer.
Autorenporträt
¿ MSc in molecular biologyInstitute of Endemic Diseases, University of Khartoum, 2008.¿ Bachelor of Science, BSC,Zoology-ChemistryFaculty of Science, University of Khartoum, 1999.¿ 2012-Currently: Lecturer, molecular biology lab Manager at University of Gezira.